Patients Are Debating The New Mychart Kansas Health System Security
参考文献:A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction.
Longtime collaboration of The University of Kansas Health System and ...
